{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:14:36Z","timestamp":1781086476268,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-024-05287-9","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T01:29:33Z","timestamp":1734571773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["An unusual case of type I hyperlipidemia - infant with acute encephalopathy, bulging fontanel, vomiting and pink blood: a case report"],"prefix":"10.1186","volume":"24","author":[{"given":"Jasna","family":"Kalanj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina Goran","family":"Cobeljic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Jesic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Zdravkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Cvetkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja","family":"Vukasinovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Andjelkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snezana","family":"Rsovac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"issue":"12","key":"5287_CR1","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00109-002-0384-9","volume":"80","author":"JR Mead","year":"2002","unstructured":"Mead JR, Irvine SA, Ramji DP. Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med (Berl). 2002;80(12):753\u201369. https:\/\/doi.org\/10.1007\/s00109-002-0384-9.","journal-title":"J Mol Med (Berl)"},{"key":"5287_CR2","unstructured":"Regmi M, Rehman A. Familial Hyperchylomicronemia Syndrome. [Updated 2023 Aug 8]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.\u00a0Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551655\/. Accessed 28 Feb 2024."},{"issue":"11","key":"5287_CR3","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.21037\/tp-22-515","volume":"11","author":"MJ Ariza","year":"2022","unstructured":"Ariza MJ, Valdivielso P. Familial chylomicronemia syndrome in children: a diagnosis challenge. Transl Pediatr. 2022;11(11):1743\u20137. https:\/\/doi.org\/10.21037\/tp-22-515.","journal-title":"Transl Pediatr"},{"issue":"3","key":"5287_CR4","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3390\/nu5030981","volume":"5","author":"A Brahm","year":"2013","unstructured":"Brahm A, Hegele RA. Hypertriglyceridemia. Nutrients. 2013;5(3):981\u20131001. https:\/\/doi.org\/10.3390\/nu5030981.","journal-title":"Nutrients"},{"key":"5287_CR5","doi-asserted-by":"publisher","first-page":"807434","DOI":"10.1155\/2010\/807434","volume":"2010","author":"H Al Azkawi","year":"2010","unstructured":"Al Azkawi H, Alalwan I. Two siblings with familial chylomicronemia syndrome: disease course and effectiveness of early treatment. Case Report Med. 2010;2010:807434. https:\/\/doi.org\/10.1155\/2010\/807434.","journal-title":"Case Report Med"},{"issue":"4","key":"5287_CR6","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jacl.2018.03.093","volume":"12","author":"RA Hegele","year":"2018","unstructured":"Hegele RA, Berberich AJ, Ban MR, Wang J, Digenio A, Alexander VJ, et al. Clinical and biochemical features of different molecular etiologies of familial chylomicronemia. J Clin Lipidol. 2018;12(4):920-927.e4. https:\/\/doi.org\/10.1016\/j.jacl.2018.03.093.","journal-title":"J Clin Lipidol"},{"issue":"10","key":"5287_CR7","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.3390\/jcm12103414","volume":"12","author":"B Cheung","year":"2023","unstructured":"Cheung B, Sikand G, Dineen EH, Malik S, Barseghian E-F. Lipid-lowering nutraceuticals for an integrative approach to dyslipidemia. J Clin Med. 2023;12(10):3414. https:\/\/doi.org\/10.3390\/jcm12103414.","journal-title":"J Clin Med"},{"key":"5287_CR8","unstructured":"Quintanilla Rodriguez BS, Correa R. Gemfibrozil. [Updated 2023 Feb 13]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK545266\/. Accessed 28 Feb 2024."},{"issue":"4","key":"5287_CR9","first-page":"306","volume":"44","author":"H Onal","year":"2007","unstructured":"Onal H, Atugluzeybek C, Alhaj S, Altun G. Encephalopathy in type I hyperlipidemia. Indian Pediatr. 2007;44(4):306\u20138.","journal-title":"Indian Pediatr"},{"issue":"2","key":"5287_CR10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1590\/2359-3997000000244","volume":"61","author":"MS Kuchay","year":"2017","unstructured":"Kuchay MS, Farooqui KJ, Bano T, Khandelwal M, Gill H, Mithal A. Heparin and insulin in the management of hypertriglyceridemia-associated pancreatitis: case series and literature review. Arch Endocrinol Metab. 2017;61(2):198\u2013201. https:\/\/doi.org\/10.1590\/2359-3997000000244.","journal-title":"Arch Endocrinol Metab"},{"key":"5287_CR11","doi-asserted-by":"publisher","first-page":"4721357","DOI":"10.1155\/2018\/4721357","volume":"2018","author":"R Garg","year":"2018","unstructured":"Garg R, Rustagi T. Management of Hypertriglyceridemia Induced Acute Pancreatitis. Biomed Res Int. 2018;2018:4721357. https:\/\/doi.org\/10.1155\/2018\/4721357.","journal-title":"Biomed Res Int"},{"issue":"1","key":"5287_CR12","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s13063-019-3498-x","volume":"20","author":"X Song","year":"2019","unstructured":"Song X, Shi D, Cui Q, et al. Intensive insulin therapy versus plasmapheresis in the management of hypertriglyceridemia-induced acute pancreatitis (Bi-TPAI trial): study protocol for a randomized controlled trial. Trials. 2019;20(1):365. https:\/\/doi.org\/10.1186\/s13063-019-3498-x.","journal-title":"Trials"},{"issue":"1","key":"5287_CR13","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.mayocpiqo.2021.02.001","volume":"5","author":"JM Reed","year":"2021","unstructured":"Reed JM, Hogan BM, Nasser-Ghodsi N, Loftus CG. Management of hypertriglyceridemia-induced acute pancreatitis in a nondiabetic patient. Mayo Clin Proc Innov Qual Outcomes. 2021;5(1):230\u20135. https:\/\/doi.org\/10.1016\/j.mayocpiqo.2021.02.001.","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"5287_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/8904_2013_272","volume":"13","author":"L Pugni","year":"2014","unstructured":"Pugni L, Riva E, Pietrasanta C, Rabacchi C, Bertolini S, Pederiva C, et al. Severe hypertriglyceridemia in a newborn with monogenic lipoprotein lipase deficiency: an unconventional therapeutic approach with exchange transfusion. JIMD Rep. 2014;13:59\u201364. https:\/\/doi.org\/10.1007\/8904_2013_272.","journal-title":"JIMD Rep"},{"key":"5287_CR15","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ejro.2019.08.003","volume":"6","author":"VT Hoang","year":"2019","unstructured":"Hoang VT, Trinh CT, Nguyen CH, Chansomphou V, Chansomphou V, Tran TTT. Overview of epidermoid cyst. Eur J Radiol Open. 2019;6:291\u2013301. https:\/\/doi.org\/10.1016\/j.ejro.2019.08.003.","journal-title":"Eur J Radiol Open"},{"key":"5287_CR16","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ijscr.2020.09.161","volume":"76","author":"D Ghartimagar","year":"2020","unstructured":"Ghartimagar D, Shrestha MK, Ghosh A. Recurrence of ruptured intracranial epidermoid cyst - a rare case report and presentation. Int J Surg Case Rep. 2020;76:310\u20134. https:\/\/doi.org\/10.1016\/j.ijscr.2020.09.161.","journal-title":"Int J Surg Case Rep"},{"issue":"2","key":"5287_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1227\/01.neu.0000316004.88517.29","volume":"62","author":"JK Liu","year":"2008","unstructured":"Liu JK, Gottfried ON, Salzman KL, Schmidt RH, Couldwell WT. Ruptured intracranial dermoid cysts: clinical, radiographic, and surgical features. Neurosurgery. 2008;62(2):377\u201384. https:\/\/doi.org\/10.1227\/01.neu.0000316004.88517.29.","journal-title":"Neurosurgery"},{"issue":"6","key":"5287_CR18","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/ana.10598","volume":"53","author":"CJ Wilson","year":"2003","unstructured":"Wilson CJ, Priore Oliva C, Maggi F, Catapano AL, Calandra S. Apolipoprotein C-II deficiency presenting as a lipid encephalopathy in infancy. Ann Neurol. 2003;53(6):807\u201310. https:\/\/doi.org\/10.1002\/ana.10598.","journal-title":"Ann Neurol"},{"issue":"1","key":"5287_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/08998280.2012.11928775","volume":"25","author":"MJ Ray","year":"2012","unstructured":"Ray MJ, Barnett DW, Snipes GJ, Layton KF, Opatowsky MJ. Ruptured intracranial dermoid cyst. Proc (Bayl Univ Med Cent). 2012;25(1):23\u20135. https:\/\/doi.org\/10.1080\/08998280.2012.11928775.","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"5287_CR20","doi-asserted-by":"publisher","first-page":"384719","DOI":"10.1155\/2012\/384719","volume":"2012","author":"YH Chen","year":"2012","unstructured":"Chen YH, Ke ZL, Wang YX, Wang Y, Zheng YZ. Two case reports of familial chylomicronemia syndrome. Case Rep Pediatr. 2012;2012:384719. https:\/\/doi.org\/10.1155\/2012\/384719.","journal-title":"Case Rep Pediatr"},{"issue":"3","key":"5287_CR21","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/s0889-8529(05)70025-6","volume":"27","author":"S Santamarina-Fojo","year":"1998","unstructured":"Santamarina-Fojo S. The familial chylomicronemia syndrome. Endocrinol Metab Clin North Am. 1998;27(3):551\u201367. https:\/\/doi.org\/10.1016\/s0889-8529(05)70025-6.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"5287_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13256-020-02609-0","volume":"15","author":"AT Susheela","year":"2021","unstructured":"Susheela AT, Vadakapet P, Pillai L, et al. Familial chylomicronemia syndrome: a case report. J Med Case Reports. 2021;15(1):5. https:\/\/doi.org\/10.1186\/s13256-020-02609-0.","journal-title":"J Med Case Reports"},{"issue":"12","key":"5287_CR23","first-page":"2134","volume":"90","author":"MR Fortson","year":"1995","unstructured":"Fortson MR, Freedman SN, Webster PD 3rd. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol. 1995;90(12):2134\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"5287_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.arteri.2021.01.004","volume":"33","author":"A Navarro Hermoso","year":"2021","unstructured":"Navarro Hermoso A, Valdivielso P. Treatment of chylomicronemia. Clin Investig Arterioscler. 2021;33(2):75\u20139. https:\/\/doi.org\/10.1016\/j.arteri.2021.01.004.","journal-title":"Clin Investig Arterioscler"},{"issue":"6","key":"5287_CR25","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1056\/NEJMoa1715944","volume":"381","author":"JL Witztum","year":"2019","unstructured":"Witztum JL, Gaudet D, Freedman SD, Alexander VJ, Digenio A, Williams KR, et al. Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome. N Engl J Med. 2019;381(6):531\u201342. https:\/\/doi.org\/10.1056\/NEJMoa1715944.","journal-title":"N Engl J Med"},{"issue":"4","key":"5287_CR26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1080\/17512433.2022.2094768","volume":"15","author":"I Shamsudeen","year":"2022","unstructured":"Shamsudeen I, Hegele RA. Safety and efficacy of therapies for chylomicronemia. Expert Rev Clin Pharmacol. 2022;15(4):395\u2013405. https:\/\/doi.org\/10.1080\/17512433.2022.2094768.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"10","key":"5287_CR27","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s11883-023-01140-z","volume":"25","author":"I Gouni-Berthold","year":"2023","unstructured":"Gouni-Berthold I, Schwarz J, Berthold HK. Updates in drug treatment of severe hypertriglyceridemia. Curr Atheroscler Rep. 2023;25(10):701\u20139. https:\/\/doi.org\/10.1007\/s11883-023-01140-z.","journal-title":"Curr Atheroscler Rep"},{"key":"5287_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.atherosclerosis.2023.05.008","volume":"375","author":"A Jones","year":"2023","unstructured":"Jones A, Peers K, Wierzbicki AS, Ramachandran R, Mansfield M, Dawson C, et al. Long-term effects of volanesorsen on triglycerides and pancreatitis in patients with familial chylomicronaemia syndrome (FCS) in the UK Early Access to Medicines Scheme (EAMS). Atherosclerosis. 2023;375:67\u201374. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.05.008.","journal-title":"Atherosclerosis"},{"issue":"3","key":"5287_CR29","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jacl.2023.03.007","volume":"17","author":"JL Witztum","year":"2023","unstructured":"Witztum JL, Gaudet D, Arca M, Jones A, Soran H, Gouni-Berthold I, et al. Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial. J Clin Lipidol. 2023;17(3):342\u201355. https:\/\/doi.org\/10.1016\/j.jacl.2023.03.007.","journal-title":"J Clin Lipidol"},{"issue":"3","key":"5287_CR30","doi-asserted-by":"publisher","first-page":"408","DOI":"10.20945\/2359-3997000000601","volume":"67","author":"W Masson","year":"2023","unstructured":"Masson W, Barbagelata L, Fleitas M, Herzkovich N, Kerschner E, Rossi E, et al. Screening program for familial hyperchylomicronemia syndrome detection: Experience of a university health system. Arch Endocrinol Metab. 2023;67(3):408\u201315. https:\/\/doi.org\/10.20945\/2359-3997000000601.","journal-title":"Arch Endocrinol Metab."},{"issue":"1","key":"5287_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12944-022-01768-x","volume":"22","author":"FH Rodriguez","year":"2023","unstructured":"Rodriguez FH, Estrada JM, Quintero HMA, Nogueira JP, Porras-Hurtado GL. Analyses of familial chylomicronemia syndrome in Pereira, Colombia 2010\u20132020: a cross-sectional study. Lipids in Health and Disease. 2023;22(1):43. https:\/\/doi.org\/10.1186\/s12944-022-01768-x.","journal-title":"Lipids in Health and Disease."}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-05287-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-024-05287-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-05287-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T02:02:45Z","timestamp":1734573765000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-024-05287-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5287"],"URL":"https:\/\/doi.org\/10.1186\/s12887-024-05287-9","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"assertion":[{"value":"13 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors certify that they have obtained all appropriate patient consent forms. In the form the patient\u2019s parents have given their consent for patient\u2019s clinical information to be reported in the journal. This case report was approved by Institutional Ethical Committee of the University Children\u2019s Hospital in Belgrade, Serbia.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s parents for publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"815"}}